Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Myopathy breakthrough paves way for new treatments
Dr Charlotte Maile and Professor Richard Piercy.

RVC study reveals mechanisms that underlie form of 'tying-up'

New research has revealed the molecular mechanisms that underlie a common form of ‘tying-up’ in horses.

Tying-up, scientifically known as Type 1 Polysaccharide Storage Myopathy (PSSM1), is a common condition that damages equine muscle tissue.  

Animals affected by the condition have a mutation of a key enzyme (glycogen synthase) which is involved in energy metabolism in muscle.

They also suffer from a build-up of polysaccharide (a form of carbohydrate) and increased storage of glycogen. Horses that carry the condition are prone to ‘tying up and muscle weakness.

Until now, nobody knew the precise mechanism by which the mutation caused increased enzyme activity in muscles. But new research, published in the journal Biochim Biohys Acta, shows that the mutation leads to a change in the enzyme’s structure, leaving it permanently active.

This hyperactivity, the team explains, accounts for the increased muscle glycogen and the accumulation of polysaccharide.

Led by
Dr Charlotte Maile and Professor Richard Piercy of the RVC, the research was conducted by an international team of scientists from the University of Copenhagen, University of Minnesota, Indiana University School of Medicine and Liverpool John Moore’s University.

It is hoped that the breakthrough will enable the team to work towards improving treatments and management for this disorder, to improve the welfare of affected horses.

"PSSM1 is a very common disease, especially in some breeds. Finally we know the reason why these horses store excessive glycogen and polysaccharide in their muscles. Our goal now is to use this information in designing new treatments and management strategies,” said Professor Richard Piercy, Professor of Comparative Neuromuscular Disease.

Prof Richard Piercy added: “Managing horses that tie-up is hard, and some recommended treatments work poorly in some animals. By revealing the precise mechanism for this form of tying up, our work should make a real difference.

“Our hope is that by targeting specific approaches to the problem, rather than a ‘one treatment fits all’ - horse welfare will be improved allowing them to get back to exercise, which has to be good for the horse and their owner”.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.